- Investing Ideas
- /
- Semiconductors Healthcare Sector
Semiconductors Healthcare Sector
Results
2311
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,311 companies
Kiniksa Pharmaceuticals International
Market Cap: US$2.0b
A biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide.
KNSA
US$25.60
7D
-5.0%
1Y
31.4%
CG Oncology
Market Cap: US$1.9b
A late-stage clinical biopharmaceutical company, develops and commercializes backbone bladder-sparing therapeutics for patients with bladder cancer.
CGON
US$24.18
7D
11.4%
1Y
-11.5%
Travere Therapeutics
Market Cap: US$1.9b
A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.
TVTX
US$20.94
7D
5.0%
1Y
212.5%
Amicus Therapeutics
Market Cap: US$1.9b
A biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.
FOLD
US$6.02
7D
-2.7%
1Y
-35.5%
Premier
Market Cap: US$1.9b
Operates as a healthcare improvement company in the United States.
PINC
US$22.86
7D
-0.3%
1Y
15.8%
Recursion Pharmaceuticals
Market Cap: US$1.9b
Operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States.
RXRX
US$4.51
7D
8.5%
1Y
-55.1%
Progyny
Market Cap: US$1.9b
A benefits management company, provides fertility, family building, and women’s health benefits solutions in the United States.
PGNY
US$21.68
7D
-7.2%
1Y
-21.1%
UFP Technologies
Market Cap: US$1.9b
Designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States.
UFPT
US$247.79
7D
12.9%
1Y
-5.7%
CONMED
Market Cap: US$1.9b
A medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures in the United States and internationally.
CNMD
US$60.05
7D
7.4%
1Y
-17.1%
LeMaitre Vascular
Market Cap: US$1.9b
Develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific.
LMAT
US$83.28
7D
1.4%
1Y
6.7%
Tarsus Pharmaceuticals
Market Cap: US$1.9b
A commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States.
TARS
US$41.46
7D
-10.7%
1Y
9.1%
Alphatec Holdings
Market Cap: US$1.9b
A medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally.
ATEC
US$12.72
7D
4.5%
1Y
17.0%
Supernus Pharmaceuticals
Market Cap: US$1.8b
A biopharmaceutical company, develops and commercializes products for the treatment of central nervous system (CNS) diseases in the United States.
SUPN
US$32.28
7D
-0.5%
1Y
11.4%
Genus
Market Cap: UK£1.3b
Operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia.
GNS
UK£20.50
7D
-1.9%
1Y
10.2%
Beam Therapeutics
Market Cap: US$1.8b
A biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States.
BEAM
US$18.05
7D
12.9%
1Y
-24.2%
Schrödinger
Market Cap: US$1.8b
Develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications.
SDGR
US$23.76
7D
0.8%
1Y
2.2%
Bausch Health Companies
Market Cap: US$1.8b
Operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally.
BHC
US$4.67
7D
-1.5%
1Y
-34.4%
Clover Health Investments
Market Cap: US$1.8b
Provides medicare advantage plans in the United States.
CLOV
US$3.40
7D
1.5%
1Y
233.3%
Centessa Pharmaceuticals
Market Cap: US$1.8b
A clinical-stage pharmaceutical company, discovers, develops, and delivers medicines.
CNTA
US$12.46
7D
3.7%
1Y
37.8%
PACS Group
Market Cap: US$1.7b
Through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States.
PACS
US$10.95
7D
11.1%
1Y
-59.3%
Arcutis Biotherapeutics
Market Cap: US$1.7b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$13.82
7D
-3.5%
1Y
70.0%
Oxford Nanopore Technologies
Market Cap: UK£1.3b
Engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows the real-time analysis of DNA or RNA.
ONT
UK£1.32
7D
4.8%
1Y
19.0%
Agios Pharmaceuticals
Market Cap: US$1.7b
A biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.
AGIO
US$28.74
7D
1.5%
1Y
-15.8%
GeneDx Holdings
Market Cap: US$1.7b
A genomics company, provides genetic testing services.
WGS
US$60.93
7D
-3.7%
1Y
185.4%
Summerset Group Holdings
Market Cap: NZ$2.8b
Develops, owns, and operates integrated retirement villages in New Zealand and Australia.
SUM
NZ$11.80
7D
9.5%
1Y
14.8%
GoodRx Holdings
Market Cap: US$1.7b
Offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States.
GDRX
US$4.30
7D
0.9%
1Y
-35.3%
Endo
Market Cap: US$1.6b
A specialty pharmaceutical company, develops, manufactures, markets, and sells various pharmaceutical products in the United States and internationally.
NDOI
US$21.41
7D
0.8%
1Y
n/a
Tivity Health
Market Cap: US$1.6b
Tivity Health, Inc. provides fitness and health products and solutions in the United States.
TVTY
US$32.50
7D
0.4%
1Y
22.2%
Disc Medicine
Market Cap: US$1.6b
A clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States.
IRON
US$46.35
7D
8.9%
1Y
45.6%
Brookdale Senior Living
Market Cap: US$1.6b
Owns, manages, and operates senior living communities in the United States.
BKD
US$6.92
7D
2.5%
1Y
-3.2%
National HealthCare
Market Cap: US$1.6b
Engages in the operation of services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals.
NHC
US$105.39
7D
10.9%
1Y
7.7%
AtriCure
Market Cap: US$1.6b
Develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally.
ATRC
US$31.48
7D
5.5%
1Y
43.8%
Tandem Diabetes Care
Market Cap: US$1.6b
Designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally.
TNDM
US$23.13
7D
8.5%
1Y
-47.5%
Edgewise Therapeutics
Market Cap: US$1.6b
A biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders.
EWTX
US$14.89
7D
3.5%
1Y
-14.6%
Janux Therapeutics
Market Cap: US$1.5b
A clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms technology to treat patients with cancer.
JANX
US$25.33
7D
-0.8%
1Y
-47.1%
Phreesia
Market Cap: US$1.5b
Provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.
PHR
US$26.10
7D
7.6%
1Y
17.7%